New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 2, 2014
09:20 EDTSQNM, RBS, NTRI, SQI, INVN, AVNR, MRK, CVX, BCOR, BIRT, IMMU, ISRG, ECYT, AXL, SREV, RXII, OPENOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Royal Bank of Scotland (RBS), up 9%... Sequenom (SQNM), up 8.2%... Nutrisystem (NTRI), up 11.5%... American Axle (AXL), up 2.9%. ALSO HIGHER: Wynn Resorts (WYNN), up 4% after earnings, shares upgraded at Sterne Agee... Avanir (AVNR), up 3.7% after upgraded at Mizuho... RXi Pharmaceuticals (RXII), up 27.4% after announcing results from study of RXI-109... Intuitive Surgical (ISRG), up 4% after announcing accelerated share repurchase. DOWN AFTER EARNINGS: Chevron (CVX), down 1%... OpenTable (OPEN), down 3.4%... Actuate (BIRT), down 18.2%... SciQuest (SQI), down 20%... ServiceSource (SREV), down 15.2%. ALSO LOWER: Endocyte (ECYT), down 60% after announcing DSMB recommends vintafolide PROCEED trial be stopped. The drug is being developed in partnership with Merck (MRK)... Immunomedics (IMMU), down 16% after filing to sell $30M worth of common stock in a spot secondary offering... InvenSense (INVN), down 9.3% after downgraded at Needham following the company's Q4 earnings report... Blucora (BCOR), down 10% after earnings, downgrade at Craig-Hallum.
News For CVX;RBS;ECYT;MRK;SQNM;ISRG;AVNR;OPEN;IMMU;INVN;RXII;BIRT;SQI;SREV;BCOR;NTRI;AXL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
June 22, 2015
06:10 EDTRBSRBS Chairman says UK banks fear block on cross-selling, Financial Times says
RBS Chairman Sir Philip Hampton has warned that British Banks fear being blocked from cross-selling products to their clients, reports the Financial Times. Hampton said UK banks had no choice but to accept the ringfencing low that forces them to hive off retail and small business operations into a separate subsidiary at arms length from other activities. Reference Link
June 21, 2015
13:14 EDTMRKMerck shares could return 25%, Barron's says
Subscribe for More Information
June 19, 2015
09:27 EDTCVXPacific Drilling tender canceled by Chevron, says Raymond James
Subscribe for More Information
05:54 EDTRBSRBS looks to hire banker who had worked on ABN deal, Financial Times reports
Subscribe for More Information
June 18, 2015
10:51 EDTRBSRBS close to returning 'missing' customer payments, The Telegraph says
Subscribe for More Information
07:28 EDTRBSLloyds CEO to call on U.K. banks to welcome ringfencing rules, Reuters says
Subscribe for More Information
06:22 EDTCVXPetrovietnam says acquires Chevron's Vietnam assets
Subscribe for More Information
June 17, 2015
17:00 EDTMRKOncoSec CEO expects 'to be in a better position to attract a strategic partner'
Subscribe for More Information
14:32 EDTIMMUImmunomedics options active
Immunomedics July 7 and August 4 calls are active on total call volume of 8K contracts (3K puts). June call option implied volatility is at 176, July is at 226, August is at 163; compared to its 52--week range of 53 to 173. Active call volume suggests traders taking positions for price movement.
10:00 EDTMRKOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: AbbVie (ABBV) initiated with an Overweight at Piper Jaffray... Arista Networks (ANET) initiated with a Buy at Sterne Agee CRT... Astec (ASTE) initiated with a Buy at Maxim... Bristol-Myers (BMY) initiated with an Underweight at Piper Jaffray... Community Healthcare (CHCT) initiated with an Outperform at Oppenheimer... Eli Lilly (LLY) initiated with an Overweight at Piper Jaffray... Fitbit (FIT) initiated with a Buy ahead of IPO at Dougherty... Hortonworks (HDP) initiated with a Buy at Mizuho... II-VI (IIVI) initiated with a Buy at Benchmark Co.... J Sainsbury (JSAIY) initiated with an Underperform at Credit Suisse... McDermott (MDR) initiated with an Outperform at Cowen... Merck (MRK) initiated with a Neutral at Piper Jaffray... Molina Healthcare (MOH) initiated with a Buy at UBS... Pacific DataVision (PDVW) initiated with a Buy at Canaccord... Pfizer (PFE) initiated with an Overweight at Piper Jaffray... Quest Resource (QRHC) initiated with a Buy at Roth Capital... Regional Management (RM) initiated with a Buy at Janney Capital... Rofin-Sinar (RSTI) initiated with a Buy at Benchmark Co.... Salesforce (CRM) initiated with a Neutral at Exane BNP Paribas... Sprouts Farmers Markets (SFM) initiated with a Neutral at Cleveland Research... Tesco (TSCDY) initiated with an Underperform at Credit Suisse... WM Morrison (MRWSY) initiated with a Neutral at Credit Suisse... WWE (WWE) initiated with a Buy at BTIG... World Acceptance (WRLD) initiated with a Buy at Janney Capital... Zafgen (ZFGN) initiated with a Buy at SunTrust.
10:00 EDTCVXOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:03 EDTAVNRAvanir's AVP-825 device for migraine shows positive results
Avanir's COMPASS Phase IIIb, cross-over clinical trial comparing the efficacy and safety of AVP-825 22mg to sumatriptan 100mg tablets for the treatment of acute migraine across multiple attacks, showed that patients treated with AVP-825 achieved pain relief and pain freedom in significantly more migraine attacks at all time points from 15-90 minutes post-dose compared to sumatriptan tablets. A New Drug Application for AVP-825 has been accepted and is currently under review by the FDA with a Prescription Drug User Fee Act goal date of November 6.
08:03 EDTMRKMerck Keytruda granted FDA orphan designation as gastric cancer treatment
The FDA granted Merck, Sharp & Dohme, a subsidiary of Merck, orphan status for Keytruda as a treatment of gastric cancer, including gastroesophageal junction adenocarcinoma. Reference Link
06:57 EDTISRGIntuitive Surgical volatility at low end of historic range
Subscribe for More Information
05:31 EDTMRKMerck initiated with a Neutral at Piper Jaffray
Subscribe for More Information
05:24 EDTCVXChevron upgraded to Buy from Hold at Societe Generale
Subscribe for More Information
June 16, 2015
14:34 EDTCVXChevron upgraded to Buy from Hold at Societe Generale
Subscribe for More Information
10:07 EDTMRKAlkermes spike attributed to takeover speculation
The spike higher in shares of Alkermes (ALKS) is being attributed by traders to speculation of a takeover. Shares jumped 6% to $61.89 in morning trading. The Ireland based drugmaker focuses on treatments of central nervous system disorders, such as addiction, schizophrenia and depression. The speculative chatter has Merck (MRK) as a potential acquirer of Alkermes. The company’s June 60 and 65 calls are actively trading, according to The Fly's options specialist.
07:21 EDTAXLDana Holding could win key GM deal, says RBC Capital
Subscribe for More Information
June 15, 2015
09:06 EDTISRGNorthland to hold a bus tour
2015 SFO Investors Bus Tour travels throughout San Francisco on June 15.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use